Integrin β1 is an essential factor in vasculogenic mimicry of human cancer cells

Ryota Kawahara, Yuki Niwa, Siro Simizu

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Vasculogenic mimicry (VM) formation by cancer cells is known to play a crucial role in tumor progression, but its detailed mechanism is unclear. In the present study, we focused on integrin β1 (ITGB1) and assessed the role of ITGB1 in VM formation. We used in vitro methods to seed cancer cells on Matrigel to evaluate the capability of VM formation. We carried out ITGB1 gene deletion using the CRISPR/Cas9 system, and these ITGB1-knockout cells did not show a VM-like network formation. Further, reintroduction of ITGB1 rescued VM-like network formation in ITGB1-knockout cells. In conclusion, ITGB1 is a critical factor in VM of human cancer cells, and inhibition of ITGB1 may be a novel therapeutic approach for malignant cancer.

Original languageEnglish
JournalCancer Science
DOIs
Publication statusAccepted/In press - 2018 Jan 1

Fingerprint

Integrins
Neoplasms
Clustered Regularly Interspaced Short Palindromic Repeats
Gene Deletion
Seeds
Therapeutics

Keywords

  • CRISPR/Cas9
  • Focal adhesion kinase
  • Integrin β1
  • Metastasis
  • Vasculogenic mimicry

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Integrin β1 is an essential factor in vasculogenic mimicry of human cancer cells. / Kawahara, Ryota; Niwa, Yuki; Simizu, Siro.

In: Cancer Science, 01.01.2018.

Research output: Contribution to journalArticle

@article{fc0c8226458645c295076587e028834e,
title = "Integrin β1 is an essential factor in vasculogenic mimicry of human cancer cells",
abstract = "Vasculogenic mimicry (VM) formation by cancer cells is known to play a crucial role in tumor progression, but its detailed mechanism is unclear. In the present study, we focused on integrin β1 (ITGB1) and assessed the role of ITGB1 in VM formation. We used in vitro methods to seed cancer cells on Matrigel to evaluate the capability of VM formation. We carried out ITGB1 gene deletion using the CRISPR/Cas9 system, and these ITGB1-knockout cells did not show a VM-like network formation. Further, reintroduction of ITGB1 rescued VM-like network formation in ITGB1-knockout cells. In conclusion, ITGB1 is a critical factor in VM of human cancer cells, and inhibition of ITGB1 may be a novel therapeutic approach for malignant cancer.",
keywords = "CRISPR/Cas9, Focal adhesion kinase, Integrin β1, Metastasis, Vasculogenic mimicry",
author = "Ryota Kawahara and Yuki Niwa and Siro Simizu",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/cas.13693",
language = "English",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Integrin β1 is an essential factor in vasculogenic mimicry of human cancer cells

AU - Kawahara, Ryota

AU - Niwa, Yuki

AU - Simizu, Siro

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Vasculogenic mimicry (VM) formation by cancer cells is known to play a crucial role in tumor progression, but its detailed mechanism is unclear. In the present study, we focused on integrin β1 (ITGB1) and assessed the role of ITGB1 in VM formation. We used in vitro methods to seed cancer cells on Matrigel to evaluate the capability of VM formation. We carried out ITGB1 gene deletion using the CRISPR/Cas9 system, and these ITGB1-knockout cells did not show a VM-like network formation. Further, reintroduction of ITGB1 rescued VM-like network formation in ITGB1-knockout cells. In conclusion, ITGB1 is a critical factor in VM of human cancer cells, and inhibition of ITGB1 may be a novel therapeutic approach for malignant cancer.

AB - Vasculogenic mimicry (VM) formation by cancer cells is known to play a crucial role in tumor progression, but its detailed mechanism is unclear. In the present study, we focused on integrin β1 (ITGB1) and assessed the role of ITGB1 in VM formation. We used in vitro methods to seed cancer cells on Matrigel to evaluate the capability of VM formation. We carried out ITGB1 gene deletion using the CRISPR/Cas9 system, and these ITGB1-knockout cells did not show a VM-like network formation. Further, reintroduction of ITGB1 rescued VM-like network formation in ITGB1-knockout cells. In conclusion, ITGB1 is a critical factor in VM of human cancer cells, and inhibition of ITGB1 may be a novel therapeutic approach for malignant cancer.

KW - CRISPR/Cas9

KW - Focal adhesion kinase

KW - Integrin β1

KW - Metastasis

KW - Vasculogenic mimicry

UR - http://www.scopus.com/inward/record.url?scp=85050950504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050950504&partnerID=8YFLogxK

U2 - 10.1111/cas.13693

DO - 10.1111/cas.13693

M3 - Article

C2 - 29900640

AN - SCOPUS:85050950504

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

ER -